Stryker stock at EUR 289.50, up 0.50% premarket
Published on 11/12/2026 at 08:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWhat Stryker Investors Should Watch
- Stryker's latest quarterly revenue rose 7.6 percent year on year, but adjusted earnings per share missed the analyst consensus.
- Management lowered its full-year 2026 organic sales growth outlook to 6.5 to 7.0 percent on October 29.
- Spencer Stiles is scheduled to become chief executive officer on January 1, 2027, with Kevin Lobo moving to executive chair.
Stryker stock traded at 289.50 euros on Lang & Schwarz at 08:28 CET on Thursday, November 12, 2026, 0.50 percent above the Xetra close of Wednesday, November 11, at 288.05 euros.
Quarterly Growth Meets Lower Guidance
Stryker's latest quarterly report showed revenue of USD 6.52 billion, up 7.6 percent from a year earlier. Adjusted earnings per share came in at USD 3.52, below the analyst consensus of USD 3.55, while revenue also missed the USD 6.62 billion estimate, according to MarketBeat.
The medical technology company sells orthopedic implants, surgical and endoscopy equipment, patient-care products and the Mako robotic-arm system. Its business remains exposed to hospital budgets and procedure volumes, while recent operating performance has been mixed across product lines.
On October 29, Stryker lowered its 2026 organic sales growth outlook to 6.5 to 7.0 percent and its adjusted diluted earnings-per-share range to USD 14.80 to USD 14.90. The revised outlook gives investors a lower benchmark for the company's next quarterly update.
The leadership transition is another upcoming focus. Spencer Stiles is scheduled to become chief executive officer on January 1, 2027, while Kevin Lobo is set to become executive chair. The next results will show whether faster-growing areas such as Ortho Tech and endoscopy can offset softer knee and hip trends.
The wider US equity market remains the relevant backdrop for this US-listed healthcare company; investors can follow the S&P 500 for broader market direction.
